AEON Global Health Corp. (AGHC)
| Market Cap | 991 |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 9.91M |
| EPS (ttm) | -1.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2 |
| Open | 0.0001 |
| Previous Close | 0.0001 |
| Day's Range | 0.0001 - 0.0001 |
| 52-Week Range | 0.0001 - 0.5000 |
| Beta | -0.46 |
| Analysts | Sell |
| Price Target | n/a |
| Earnings Date | n/a |
About AGHC
Aeon Global Health Corp., together with its subsidiaries, provides various clinical laboratory testing services in the United States. The company operates through Laboratory Testing Services and Web-Based Software segments. Its laboratory testing services include the testing of an individual's blood, urine, or saliva for the presence of drugs or chemicals, as well as the patient's DNA profile. The company primarily offers medical toxicology, DNA pharmacogenomics, cancer genetic testing, and molecular biology tests. It also provides Web-based se... [Read more...]
Financial Performance
In 2019, AGHC's revenue was $12.93 million, a decrease of -20.67% compared to the previous year's $16.30 million. Losses were -$7.98 million, -0.31% less than in 2018.
Financial StatementsAnalyst Forecast
No stock price forecast available yet.